# Sanfilippo John B & Son Inc: overview

JBSS · Nasdaq · CIK 880117 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 28

Pages: [Overview](/companies/jbss.md) · [Financials](/companies/jbss/financials.md) · [Filings](/companies/jbss/filings.md) · [Insiders](/companies/jbss/insiders.md)

Latest reported revenue: [$280.4m](/filings/0001193125-26-356919.md) for Q4 FY2026, three months to 2026-06-25, from the 10-K filed Aug 19, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-356919).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-09-26) | Q2 FY2025 (2024-12-26) | Q3 FY2025 (2025-03-27) | Q4 FY2025 (2025-06-26) | Q1 FY2026 (2025-09-25) | Q2 FY2026 (2025-12-25) | Q3 FY2026 (2026-03-26) | Q4 FY2026 (2026-06-25) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [276](/filings/0001193125-25-256406.md) | [301](/filings/0001193125-26-029438.md) | [261](/filings/0001193125-26-191644.md) | [269 d](/filings/0001193125-26-356919.md) | [299](/filings/0001193125-25-256406.md) | [315](/filings/0001193125-26-029438.md) | [282](/filings/0001193125-26-191644.md) | [280 d](/filings/0001193125-26-356919.md) |
| Gross margin | % | [16.9%](/filings/0001193125-25-256406.md) | [17.4%](/filings/0001193125-26-029438.md) | [21.4%](/filings/0001193125-26-191644.md) | [18.1% d](/filings/0001193125-26-356919.md) | [18.1%](/filings/0001193125-25-256406.md) | [18.8%](/filings/0001193125-26-029438.md) | [19.1%](/filings/0001193125-26-191644.md) | [15.7% d](/filings/0001193125-26-356919.md) |
| Operating margin | % | [6.2%](/filings/0001193125-25-256406.md) | [6.4%](/filings/0001193125-26-029438.md) | [10.8%](/filings/0001193125-26-191644.md) | [7.5% d](/filings/0001193125-26-356919.md) | [9.0%](/filings/0001193125-25-256406.md) | [8.3%](/filings/0001193125-26-029438.md) | [8.4%](/filings/0001193125-26-191644.md) | [4.4% d](/filings/0001193125-26-356919.md) |
| Net margin | % | [4.2%](/filings/0001193125-26-191644.md) | [4.5%](/filings/0001193125-26-191644.md) | [7.7%](/filings/0001193125-26-191644.md) | [5.0% d](/filings/0001193125-26-356919.md) | [6.3%](/filings/0001193125-26-191644.md) | [5.7%](/filings/0001193125-26-191644.md) | [6.0%](/filings/0001193125-26-191644.md) | [3.0% d](/filings/0001193125-26-356919.md) |
| Diluted EPS | $ per share | [1.00](/filings/0001193125-25-256406.md) | [1.16](/filings/0001193125-26-029438.md) | [1.72](/filings/0001193125-26-191644.md) | not reported | [1.59](/filings/0001193125-25-256406.md) | [1.53](/filings/0001193125-26-029438.md) | [1.43](/filings/0001193125-26-191644.md) | not reported |
| Free cash flow | $m | [(3.0)](/filings/0001193125-25-256406.md) | [(2.7) d](/filings/0001193125-26-029438.md) | [(37.6) d](/filings/0001193125-26-191644.md) | [23.0 d](/filings/0001193125-26-356919.md) | [7.3](/filings/0001193125-25-256406.md) | [40.0 d](/filings/0001193125-26-029438.md) | [(21.5) d](/filings/0001193125-26-191644.md) | [9.9 d](/filings/0001193125-26-356919.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-29) | FY2024 (2024-06-27) | FY2025 (2025-06-26) | FY2026 (2026-06-25) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [956](/filings/0000950170-24-099489.md) | [1,000](/filings/0000950170-25-110463.md) | [1,067](/filings/0001193125-26-356919.md) | [1,107](/filings/0001193125-26-356919.md) | [1,176](/filings/0001193125-26-356919.md) |
| Gross margin | % | [20.9%](/filings/0000950170-24-099489.md) | [21.2%](/filings/0000950170-25-110463.md) | [20.1%](/filings/0001193125-26-356919.md) | [18.4%](/filings/0001193125-26-356919.md) | [18.0%](/filings/0001193125-26-356919.md) |
| Operating margin | % | [9.1%](/filings/0000950170-24-099489.md) | [9.0%](/filings/0000950170-25-110463.md) | [8.0%](/filings/0001193125-26-356919.md) | [7.7%](/filings/0001193125-26-356919.md) | [7.6%](/filings/0001193125-26-356919.md) |
| Net margin | % | [6.5%](/filings/0000950170-24-099489.md) | [6.3%](/filings/0000950170-25-110463.md) | [5.6%](/filings/0001193125-26-356919.md) | [5.3%](/filings/0001193125-26-356919.md) | [5.3%](/filings/0001193125-26-356919.md) |
| Diluted EPS | $ per share | [5.33](/filings/0000950170-24-099489.md) | [5.40](/filings/0000950170-25-110463.md) | [5.15](/filings/0001193125-26-356919.md) | [5.03](/filings/0001193125-26-356919.md) | [5.26](/filings/0001193125-26-356919.md) |
| Free cash flow | $m | [1.9](/filings/0000950170-24-099489.md) | [104](/filings/0000950170-25-110463.md) | [73.4](/filings/0001193125-26-356919.md) | [(20.2)](/filings/0001193125-26-356919.md) | [35.7](/filings/0001193125-26-356919.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/jbss/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $128.3m | 1,492,212 |  | Added +76,602 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $31.9m | 370,885 |  | Added +53,251 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $31.4m | 364,871 |  | Added +17,503 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $29.4m | 342,213 |  | Reduced −38,327 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $29.1m | 338,753 |  | Added +25,951 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $24.1m | 279,912 |  | Added +134,847 |
| [DEUTSCHE BANK AG\\](/funds/948046.md) | 2026-06-30 | $22.3m | 258,897 |  | Added +1,182 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $19.3m | 224,084 |  | Added +15,017 |
| [GAMCO INVESTORS, INC. ET AL](/funds/807249.md) | 2026-06-30 | $16.0m | 186,525 |  | Reduced −5,500 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $15.4m | 178,549 |  | Added +78,504 |

## Recent filings

[All 1,011 filings](/companies/jbss/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 09:31 ET | [8-K](/filings/0001193125-26-440035.md) | 5.07 Shareholder vote results | 0001193125-26-440035 |
| 2026-10-30 | 09:28 ET | [8-K/A](/filings/0001193125-26-440031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-440031 |
| 2026-10-28 | 16:14 ET | [10-Q](/filings/0001193125-26-436164.md) | Quarterly report, period 2026-09-24 | 0001193125-26-436164 |
| 2026-10-28 | 16:13 ET | [8-K](/filings/0001193125-26-436158.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436158 |
| 2026-10-02 | 16:16 ET | [8-K](/filings/0001193125-26-412309.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-412309 |
| 2026-09-14 | 16:14 ET | [DEF 14A](/filings/0001193125-26-390588.md) | Proxy statement, period 2026-09-14 | 0001193125-26-390588 |
| 2026-08-25 | 09:25 ET | [8-K](/filings/0001193125-26-364284.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-364284 |
| 2026-08-19 | 16:17 ET | [10-K](/filings/0001193125-26-356919.md) | Annual report, period 2026-06-25 | 0001193125-26-356919 |
| 2026-08-19 | 16:13 ET | [8-K](/filings/0001193125-26-356911.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-356911 |
| 2026-07-16 | 16:15 ET | [8-K](/filings/0001193125-26-306138.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-306138 |

## Latest annual report

[Form 10-K for the fiscal year ended Jun 25, 2026](/filings/0001193125-26-356919.md), filed Aug 19, 2026.

## Forecast league

Q1 FY2027, the quarter ended 2026-09-25, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/33fe2f0e-0500-44f8-9ce7-27b1791104c9)

## About the filer

- CIK: 880117
- Tickers: JBSS
- Exchange: Nasdaq
- SIC code: 2060 Sugar & Confectionery Products
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 09:32 ET. No prices; not investment advice.